Overview
PDS Biotech’s infectious disease pipeline combines the Infectimune™ platform technology with pathogen-specific antigens in the development of preventive infectious disease vaccines.
Infectious Disease
| Products | Indication | Combination | PC | P1 | P2 | P3 | R | PARTNER(S) | |
|---|---|---|---|---|---|---|---|---|---|
| Infectious Disease | |||||||||
| PDS0201 (M-tuberculosis) |
Prevention of tuberculosis |
|
|
 |
|||||
| PDS0202 (influenza) |
Universal prevention of influenza |
|
|
 |
|||||
| PDS0203 (SARS-CoV-2) |
Prevention of COVID-19 |
|
|
||||||
PDS Biotech Funded  |
Partner Co-Funded  |
||||||||